المؤلفون: Altuntas, Fevzi, Ferhanoglu, Burhan, Tuglular, Tulin Firat, MEHTAP, ÖZGÜR, Dal, Mehmet Sinan, Ulu, Bahar Uncu, UZAY, Ant, Akay, Olga Meltem, Besisik, Sevgi, Yenerel, Mustafa Nuri, ÇELİK, SERHAT, Kaynar, Leylagul, YÜCEL, ORHAN KEMAL, Deveci, Burak, SÖNMEZ, MEHMET, Bekoz, Huseyin Saffet, Sunu, Cenk, SALİM, OZAN, Ulas, Turgay, Karti, Sami

العلاقة: b6234c55-fa08-48f6-98b5-80650f4ac594; https://avesis.kocaeli.edu.tr/publication/details/b6234c55-fa08-48f6-98b5-80650f4ac594/oaiTest

الإتاحة: https://doi.org/10.1007/s00277-022-05052-xTest
https://avesis.kocaeli.edu.tr/publication/details/b6234c55-fa08-48f6-98b5-80650f4ac594/oaiTest

المؤلفون: Birtaş Ateşoğlu, Elif, Gülbaş, Zafer, Uzay, Ant, Özcan, Muhit, Özkalemkaş, Fahir, Dal, Mehmet Sinan, Kalyon, Hakan, Akay, Olga Meltem, Ferhanoğlu, Burhan

مصطلحات موضوعية: Bispecific Antibodies, Glofitamab, Relapsed/Refractory Diffuse Large B‐Cell Lymphoma

وصف الملف: application/pdf

العلاقة: Hematological Oncology; Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı; Birtaş Ateşoğlu, E., Gülbaş, Z., Uzay, A., Özcan, M., Özkalemkaş, F. ve Dal, M. S. (2023). Glofitamab in relapsed/refractory diffuse large B-cell lymphoma: Real-world data. Hematological Oncology, 41(4), 663-673. https://dx.doi.org/10.1002/hon.3174Test; https://dx.doi.org/10.1002/hon.3174Test; https://hdl.handle.net/20.500.12511/12173Test; 41; 663; 673; Q2; 000991717000001; 2-s2.0-85159808449; Q1

الإتاحة: https://doi.org/20.500.12511/12173Test
https://doi.org/10.1002/hon.3174Test
https://hdl.handle.net/20.500.12511/12173Test

المؤلفون: Dal, Mehmet Sinan, Ulu, Bahar Uncu, Uzay, Ant, Akay, Olga Meltem, Beşışık, Sevgi, Yenerel, Mustafa Nuri, Çelik, Serhat, Kaynar, Leylagül, Yücel, Orhan Kemal, Deveci, Burak, Sönmez, Mehmet, Mehtap, Özgür, Beköz, Hüseyin Saffet, Sunu, Cenk, Salim, Ozan, Ulaş, Turgay, Kartı, Sami, Altuntaş, Fevzi, Ferhanoğlu, Burhan, Tuğlular, Tülin Fırat

مصطلحات موضوعية: Bendamustine, Diffuse Large B-cell Lymphoma, Polatuzumab Vedotin, Refractory, Relapsed, Rituximab

وصف الملف: application/pdf

العلاقة: Annals of Hematology; Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı; Dal, M. S., Ulu, B. U., Uzay, A., Akay, O. M., Beşışık, S., Yenerel, M. N. . Tuğlular, T. F. (2023). Polatuzumab vedotin, rituximab, and bendamustine combination in relapsed or refractory diffuse large B-cell lymphoma: A real-world data from Turkey. Annals of Hematology, 102(1), 133-140. https://doi.org/10.1007/s00277-022-05052-xTest; https://doi.org/10.1007/s00277-022-05052-xTest; https://hdl.handle.net/20.500.12511/10517Test; 102; 133; 140; Q2; 000885401400002; 2-s2.0-85142265282; Q1

الإتاحة: https://doi.org/20.500.12511/10517Test
https://doi.org/10.1007/s00277-022-05052-xTest
https://hdl.handle.net/20.500.12511/10517Test

المؤلفون: Ferhanoğlu, Burhan, Gülbaş, Zafer, Uzay, Ant, Özcan, Muhit, Özkalemkaş, Fahir, Dal, Mehmet Sinan, Kalyon, Hakan, Akay, Olga Meltem, Deveci, Burak, Bekoz, Hüseyin, Sevindik, Ömür Gökmen, Toptaş, Tayfur, Yılmaz, Asu Fergün, Koyun, Derya, Alkış, Nihan, Birtaş Ateşoğlu, Elif

مصطلحات موضوعية: Relapsed/Refractory, Real World Data, Diffuse Large B Cell

وصف الملف: application/pdf

العلاقة: Blood; Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı; Ferhanoğlu, B., Gülbaş, Z., Uzay, A., Özcan, M., Özkalemkaş, F., Dal, M. S. . Birtaş Ateşoğlu, E. (2022). Glofitamab in relapsed/refractory diffuse large B cell lymphoma: Real world data. Blood içinde (6704-6705. ss.). https://doi.org/10.1182/blood-2022-165385Test; https://doi.org/10.1182/blood-2022-165385Test; https://hdl.handle.net/20.500.12511/10604Test; 140; Supplement: 1; 6704; 6705; Q1; 000893223206319

الإتاحة: https://doi.org/20.500.12511/10604Test
https://doi.org/10.1182/blood-2022-165385Test
https://hdl.handle.net/20.500.12511/10604Test

المؤلفون: Cilek, Neslihan, Ugurel, Elif, Eren, Ozgur Can, Yalcin, Ozlem, Akay, Olga Meltem

المصدر: Therapeutic Apheresis & Dialysis; Aug2024, Vol. 28 Issue 4, p657-663, 7p

المؤلفون: Goren Sahin, Deniz, Akay, Olga Meltem, Keklik, Muzaffer, Okan, Vahap, Karakus, Abdullah, Demir, Cengiz, Erkurt, Mehmet Ali, Ilkkilic, Kadir, Yildirim, Rahsan, Aksu, Salih, Dogu, Mehmet Hilmi, Dal, Mehmet Sinan, Karakus, Volkan, Gemici, Ali Ihsan, Terzi, Hatice, Kelkitli, Engin, Sivgin, Serdar, Unal, Ali, Yilmaz, Mehmet, Ayyildiz, Orhan, Korkmaz, Serdal, Eser, Bulent, Altuntas, Fevzi, Akgun Cagliyan, Gulsum

مصطلحات موضوعية: Management, Anchor, Defect, Eculizumab, Hemolysis, Paroxysmal nocturnal hemoglobinuria, Thrombosis, Complement Inhibitor Eculizumab, Natural-History, Diagnosis, Microparticles

العلاقة: Annals Of Hematology; Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı; https://doi.org/10.1007/s00277-021-04554-4Test; https://hdl.handle.net/11499/46365Test; 100; 1667; 1675; 2-s2.0-85105936013; WOS:000650535000001

الإتاحة: https://doi.org/10.1007/s00277-021-04554-4Test
https://hdl.handle.net/11499/46365Test

المؤلفون: Davulcu, Eren Arslan, Ferhanoglu, Burhan, Cekdemir, Demet, GÜRKAN, EMEL, Seyhanli, Ahmet, ÜNAL, ALİ, AKDENİZ, AYDAN, Dogu, Mehmet Hilmi, Basturk, Abdulkadir, Akay, Olga Meltem, Ertop, Sehmus, Sahip, Birsen, Gunes, Ahmet Kursad, Ozkocamaz, Vildan, YILDIRIM, Rahşan, Batur, Derya Selim, SÖNMEZ, MEHMET, Kurtoglu, Erdal, BERBER, İLHAMİ, TURGUT, BURHAN, Akpinar, Seval, Ozet, Gulsum, Ucar, Mehmet Ali, İLHAN, GÜL, SAYDAM, GÜRAY, AYDOĞDU, İSMET, Demircioglu, Sinan, ÇETİN, GÜVEN, Ozcan, Omer, Kizikli, Alperen, Okan, Vahap, YILMAZ, MEHMET, SAYINALP, NİLGÜN, OKAY, MÜFİDE, TERZİ, HATİCE, ÖZCAN, MEHMET ALİ, Deveci, Burak, MEHTAP, ÖZGÜR, YAVAŞOĞLU, İRFAN, ÜMİT, ELİF GÜLSÜM, KAYA, EMİN, DİNÇYÜREK, HÜSEYİN DERYA, Durusoy, Salih Sertac, Tanrikulu, Funda Pepedil, TOMBAK, ANIL

العلاقة: c1632ed4-580e-4fa3-b259-082b3ab0afda; https://avesis.deu.edu.tr/publication/details/c1632ed4-580e-4fa3-b259-082b3ab0afda/oaiTest

الإتاحة: https://doi.org/10.4274/tjh.galenos.2021.2021.0007Test
https://avesis.deu.edu.tr/publication/details/c1632ed4-580e-4fa3-b259-082b3ab0afda/oaiTest

المؤلفون: IŞIK, SEVGİ, ÜSKÜDAR TEKE, HAVA, Aslan, Abdulvahap, Yavasoglu, Filiz, Inci, Nur Sena, ÇİLİNGİR, OĞUZ, ÖZEN, HÜLYA, DEMİRKAN, FATİH, Gulbas, Zafer, ARTAN, SEVİLHAN, DURAK ARAS, BEYHAN, Akay, Olga Meltem, Gunden, Gulcin, BULDUK, TUBA, ERZURUMLUOĞLU GÖKALP, EBRU, KOCAGİL, SİNEM

العلاقة: ad549842-7689-4b9b-ae3d-cd36342e795b; https://avesis.deu.edu.tr/publication/details/ad549842-7689-4b9b-ae3d-cd36342e795b/oaiTest

الإتاحة: https://doi.org/10.1186/s13039-020-00522-1Test
https://avesis.deu.edu.tr/publication/details/ad549842-7689-4b9b-ae3d-cd36342e795b/oaiTest

المؤلفون: Şahin, Deniz Gören, Akay, Olga Meltem, Keklik, Muzaffer, Okan, Vahap, Karakuş, Abdullah, Demir, Cengiz, Erkurt, Mehmet Ali, İlkkılıç, Kadir, Yıldırım, Rahşan, Çağlıyan, Gülsüm Akgün, Aksu, Salih, Doğu, Mehmet Hilmi, Dal, Mehmet Sinan, Karakuş, Volkan, Gemici, Ali İhsan, Terzi, Hatice, Kelkitli, Engin, Şıvgn, Serdar, Ünal, Ali, Yılmaz, Mehmet, Ayyıldız, Orhan, Korkmaz, Serdal, Eser, Bülent, Altuntaş, Fevzi

مصطلحات موضوعية: Eculizumab, Hemolysis, Paroxysmal nocturnal hemoglobinuria, Thrombosis

وصف الملف: application/pdf

العلاقة: Annals of Hematology; Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı; Şahin, D.G., Akay, O.M., Keklik, M., Okan, V., Karakuş, A, Demir, C. ve diğerleri. (2021). Clinical characteristics and therapeutic outcomes of paroxysmal nocturnal hemoglobinuria patients in Turkey: a multicenter experience. Annals of Hematology, 100(7), 1667-1675. https://doiTest. org/10.1007/s00277-021-04554-4; https://link.springer.com/article/10.1007/s00277-021-04554-4Test; https://hdl.handle.net/11468/10230Test; 100; 1667; 1675; WOS:000650535000001; 2-s2.0-85105936013; Q1; Q2

الإتاحة: https://doi.org/10.1007/s00277-021-04554-4Test
https://hdl.handle.net/11468/10230Test

المؤلفون: Durak Aras, Beyhan, Işık, Sevgi, Üsküdar Teke, Hava, Aslan, Abdulvahab, Yavaşoğlu, Filiz, Gülbaş, Zafer, Demirkan, Fatih, Özen, Hülya, Çilingir, Oğuz, İnci, Nur Sena, Günden, Gülçin, Bulduk, Tuba, Erzurumluoğlu Gökalp, Ebru, Kocagil, Sinem, Artan, Sevilhan, Akay, Olga Meltem

المساهمون: Yavaşoğlu, Filiz

مصطلحات موضوعية: 13q deletions, B-CLL, FISH, Prognostic marker, RB1 deletions

وصف الملف: application/pdf

العلاقة: Molecular Cytogenetics; Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı; Durak Aras, B., Isik, S., Uskudar Teke, H., Aslan, A., Yavasoglu, F., Gulbas, Z., . & Akay, O. M. (2021). Which prognostic marker is responsible for the clinical heterogeneity in CLL with 13q deletion?. Molecular Cytogenetics, 14(1), 1-7.; https://doi.org/10.1186/s13039-020-00522-1Test; https://hdl.handle.net/20.500.12933/1157Test; 14

الإتاحة: https://doi.org/20.500.12933/1157Test
https://doi.org/10.1186/s13039-020-00522-1Test
https://hdl.handle.net/20.500.12933/1157Test